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Perioperative Course
Patient underwent general endotracheal anesthesia with 
addition of a 16G PIV and a radial arterial line. 4 units of 
PRBC were available on standby. 
Vitals remained stable throughout the course with total 
phenylephrine boluses of 1000 mcg over approximately 4 
hours. No blood products were administered. 
Total IV fluids were 2300 mL of lactated ringers and 500 mL 
of 5% albumin. Estimated blood loss was 900 mL.
The patient was extubated and taken to the recovery room. 
Immediate post-operative hemoglobin was 11.7 with factor 
VIII activity 105%. 
Hematology continued to follow the patient and checked 
factor VIII activity daily with the goal of infusing 
recombinant factor VIII 25 IU/kg for activity below 80%. No 
additional recombinant factor VIII was needed. 
Patient was discharged on post-operative day 6 without 
complications and hemoglobin of 9.0.
Preoperative Evaluation
The World Federation of Hemophilia 
recommends preoperative factor VIII levels of 
50-80% for minor surgery and 80-100% for 
major surgery.
Patient was admitted prior to surgery with 
baseline factor VIII activity 45%. Hematology 
was consulted. Repeat Factor VIII activity was 
48%, platelets 68,000.
Preoperatively, our patient received 50 IU/kg 
(4660 IU) infusion of recombinant factor VIII 
(Advate) on the day of surgery. Repeat factor 
VIII activity was 140%. Hemoglobin was 14.7. 
He had a 20G PIV in situ.
Case Presentation
Hemophilia A is an x-linked recessive hereditary disorder with factor VIII 
deficiency. This can lead to bleeding, clotting, and other intraoperative 
complications. Goals of care during the perioperative period involve optimizing 
both factor VIII activity and coagulation profile. If needed, adequate 
replacement of factor VIII levels is key to preoperative optimization.
A 68-year-old male with hypertension, hepatitis C, hemophilia A, and newly 
diagnosed cholangiocarcinoma in segment 6 of the liver presented for partial 
hepatectomy. Medications included amlodipine, hydrochlorothiazide, lisinopril, 
and clonidine. Review of symptoms was pertinent for fatigue and back pain. 
Physical exam and labs were within normal limits. 
Discussion
Historically, elective surgery was not performed on patients with 
hemophilia, but in the setting of cholangiocarcinoma, surgery is the only 
hope for cure. Partial hepatectomy in patients with hemophilia A can lead 
to disastrous consequences if bleeding is not controlled. There are no 
standard guidelines for the anesthetic management of these patients. 
One case study series described successful hepatectomy with median 
bolus injections of recombinant factor VIII of 3000 IU followed by 
continuous infusions of 4 IU/kg/h until 7-14 days after surgery. Another 
case with 887 mL blood loss gave an additional 2000 IU intraoperatively 
followed by 5 IU/kg/h until 7 days after surgery. Our patient only required 
one preoperative recombinant factor VIII bolus.    
If preoperative factor VIII levels had been below 80%, hematology would 
have recommended an additional 25 IU/kg recombinant factor VIII 
infusion prior to surgery.
In the event of ongoing bleeding, additional blood products such as 
PRBC, FFP, platelets, and cryoprecipitate could have been administered. 
We discussed with pharmacy and had plans in place for additional 
recombinant factor VIII infusion intraoperatively if necessary. We did not 
discuss a continuous postoperative infusion. Thromboelastogram could 
also provide useful information to guide blood product administration.
Conclusions
Early consultation with hematology, monitoring factor VIII activity level, 
and administration of recombinant factor VIII was critical to our patient’s 
successful anesthetic outcome. It is important to have multi-disciplinary 
discussions to come up with a cohesive perioperative plan when caring 
for patients with hemophilia A.
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